Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dyadic International 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 USA

P: 561-743-8333 F: 561-743-8343

Description:

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms including humans found in the earth's biodiversity. Using its integrated technology platform, Dyadic develops biological products such as proteins, enzymes, polypeptides and small molecules for applications in large segments of the agricultural, industrial, chemical and biopharmaceutical industries. By utilizing a proprietary host organism, Dyadic's `one-stop shop` technology rapidly discovers and expresses eukaryotic genes the genes of complex living organisms and then manufactures those unique biological products for commercial application. Dyadic's systems overcome the inadequacy of existing gene discovery and product development techniques.

Key Statistics

Overview:

Market Capitalization, $K 177,035
Shares Outstanding, K 27,111
Annual Sales, $ 760 K
Annual Net Income, $ -2,140 K
Last Quarter Sales, $ 390 K
Last Quarter Net Income, $ -2,700 K
60-Month Beta 0.19
% of Insider Shareholders 23.90%
% of Institutional Shareholders 13.09%
Float, K 20,631
% Float 76.10%

Growth:

1-Year Return 242.24%
3-Year Return 298.17%
5-Year Return 347.26%
5-Year Revenue Growth -95.13%
5-Year Earnings Growth -950.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/12/19
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year -66.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

DYAI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -6.73
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 0.00
Return-on-Assets (Before Tax) 0.00
Profit Margin % -281.58
Net Margin % -55.12
Debt/Equity 0.00
Price/Sales 101.16
Price/Cash Flow N/A
Price/Book 4.62
Book Value/Share 1.44
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar